TrialEndocrine2018
Efficacy and safety of long-acting pasireotide in patients with somatostatin-resistant acromegaly: a multicenter study.
Ilan Shimon et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this paperpooled itcites it